Scleroderma Diagnostics and Therapeutics Market Value to Reach US$ 3,663.7 Million by 2024
TMR estimates that the global scleroderma diagnostics and therapeutics market will expand at a CAGR of 9.7% from 2016 to 2024 and rise from US$1,633.5 mn in 2015 to US$3,663.7 mn by 2024.
View full press release